Houlihan Lokey is pleased to announce that GeBBS Healthcare Solutions has been acquired by ChrysCapital. The transaction closed on December 3, 2018.

Headquartered in Culver City, California, GeBBS Healthcare Solutions (GeBBS) is a leading provider of technology-enabled revenue cycle management solutions to blue-chip healthcare providers and government payers. The company delivers an integrated platform of best-in-class health information management, revenue cycle management, patient contact, risk adjustment, and quality solutions that leverage technology and global delivery capabilities to accelerate revenue, contain costs, and increase compliance. Managing in excess of $3.5 billion in accounts receivable and coding 45 million charts annually, GeBBS is a highly scalable, quality-driven partner to some of the largest health systems, physician groups, and health plans in the U.S.

GeBBS has an impressive track record of leveraging global delivery capabilities to deliver market-leading revenue cycle management and health information management solutions to its healthcare clients. ChrysCapital's investment in GeBBS demonstrates the tremendous growth prospects and market opportunity for these solutions. GeBBS' comprehensive offering addresses critical industry pain points for healthcare providers and government payers by enhancing revenue, increasing collections, reducing costs, and managing risk in a value-based care environment.

ChrysCapital is a leading India focused investment firm with approximately $3 billion of assets under management across seven funds. With over 80 investments since 1999, ChrysCapital targets investments across a range of sectors, including business services, financial services, pharmaceuticals, healthcare, consumer, and manufacturing. ChrysCapital's investors include global endowments, sovereign funds, family offices, foundations, and fund of funds. The firm's current and past investments include HCL Technologies, L&T Infotech, LiquidHub, Infogain, Mankind Pharma, Hero FinCorp, and the National Stock Exchange of India.

This transaction represents Houlihan Lokey's continued leadership and momentum in the healthcare technology and tech-enabled services sector, having advised on 24 transactions since 2015. Houlihan Lokey's Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2017, the group closed 21 transactions and was ranked the No. 1 advisor for U.S. healthcare M&A transactions under $1 billion by Thomson Reuters. Houlihan Lokey's Healthcare Group has closed more than 300 M&A healthcare transactions since inception.

Houlihan Lokey served as the exclusive financial advisor to GeBBS Healthcare Solutions and assisted in initiating, structuring, and negotiating the transaction on its behalf. 

If you would like more information about Houlihan Lokey or have any questions regarding our role in this transaction, please contact one of the deal team members listed below.

* * * * * * *

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia‑Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.